The main challenge youd run into is that investors wouldnt give you money
So far, GLP-1 drugs seem to satisfy each of those requirements
And you get better glycemic control
Specifically, Ch2-Ch1 (B1-B2 map) RICS analysis of brightness (intensity of fluorescence signal) in one channel cross-correlates with brightness in the second channel, allowing for the calculation of cross-correlation
But researchers encounter other formulations too, and understanding the differences prevents serious errors
Specifically, fatty acids (such as SCFAs, BCFAs, and conjugated polyunsaturated fatty acids), lactic acid, vitamins (including vitamins B and menaquinones), tryptophan derivatives (such as indole derivatives and 3-hydroxyanthranilic acid (3-HAA)), neurotransmitters (GABA, dopamine, and norepinephrine), deconjugated bile acids, polysaccharides (bacterial and fungal EPSs, such as dextran and -glucans), fungal-derived secondary metabolites (tyrosol and farnesol) and polyphenol-derived secondary metabolites (equol and urolithins) were described
